Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia

Biomaterials

Volumn 33, Issue 33, 2012, Pages 8529-8539

  Gámez Sazo, Rodolfo E ^a   Maenaka, Katsumi ^b   Gu, Weiyong ^c   Wood, Patrick M ^a   Bunge, Mary Bartlett ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c University of Miami College of Engineering   (United States)

Author keywords

Dorsal root ganglia; Drug sustained release; Gelatin; Photo co immobilization; Schwann cells; Spinal cord injury

Indexed keywords

DORSAL ROOT GANGLIA; GELATIN; PHOTO-CO-IMMOBILIZATION; SCHWANN CELLS; SPINAL CORD INJURIES (SCI); SUSTAINED RELEASE;

BIOCOMPATIBILITY; CROSSLINKING; ENZYME INHIBITION; FABRICATION; MEMBRANES; NEURONS; TUBES (COMPONENTS);

SCAFFOLDS (BIOLOGY);

ENHANCED GREEN FLUORESCENT PROTEIN; FIBRONECTIN; GELATIN; LAMININ; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; RECOMBINANT GROWTH FACTOR; RECOMBINANT HUMAN NEUROTROPHIN 3; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMECHANICS; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR MATRIX; FEMALE; IN VITRO STUDY; NANOFABRICATION; NERVE FIBER GROWTH; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; PROTEIN IMMOBILIZATION; PROTEIN SECRETION; RAT; SCHWANN CELL; SPINAL CORD REGENERATION; SPINAL CORD TRANSSECTION; SPINAL GANGLION;

ANIMALS; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; GANGLIA, SPINAL; GELATIN; LAMININ; NERVE GROWTH FACTORS; RATS; SCHWANN CELLS; TISSUE SCAFFOLDS;

EID: 84866179258     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.07.028     Document Type: Article

References (57)

1. Young S., Wong M., Tabata Y., Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005, 109(1-3):256-274.
2. Fujita N., Matsushita T., Ishida K., Sasaki K., Kubo S., Matsumoto T., et al. An analysis of bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein 2 from a biodegradable sponge composed of gelatin and beta-tricalcium phosphate. J Tissue Eng Regen Med 2012, 6(4):291-298.
3. Okino H., Manabe T., Tanaka M., Matsuda T. Novel therapeutic strategy for prevention of malignant tumor recurrence after surgery: local delivery and prolonged release of adenovirus immobilized in photocured, tissue-adhesive gelatinous matrix. J Biomed Mater Res A 2003, 66(3):643-651.
4. Masuda T., Furue M., Matsuda T. Photocured, styrenated gelatin-based microspheres for de novo adipogenesis through corelease of basic fibroblast growth factor, insulin, and insulin-like growth factor I. Tissue Eng 2004, 10(3-4):523-535.
5. Gamez E., Goto Y., Nagata K., Iwaki T., Sasaki T., Matsuda T. Photofabricated gelatin-based nerve conduits: nerve tissue regeneration potentials. Cell Transplant 2004, 13(5):549-564.
6. Gamez E., Ikezaki K., Fukui M., Matsuda T. Photoconstructs of nerve guidance prosthesis using photoreactive gelatin as a scaffold. Cell Transplant 2003, 12(5):481-490.
7. Johnson P.J., Tatara A., McCreedy D.A., Shiu A., Sakiyama-Elbert S.E. Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter 2010, 6(20):5127-5137.
8. Cirillo G., Cavaliere C., Bianco M.R., De Simone A., Colangelo A.M., Sellitti S., et al. Intrathecal NGF administration reduces reactive astrocytosis and changes neurotrophin receptors expression pattern in a rat model of neuropathic pain. Cell Mol Neurobiol 2010, 30(1):51-62.
9. Blits B., Oudega M., Boer G.J., Bartlett Bunge M., Verhaagen J. Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function. Neuroscience 2003, 118(1):271-281.
10. Lee T.T., Green B.A., Dietrich W.D., Yezierski R.P. Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat. J Neurotrauma 1999, 16(5):347-356.
11. Bove J.R. Fibrinogen-is the benefit worth the risk?. Transfusion 1978, 18(2):129-136.
12. Blits B., Boer G.J., Verhaagen J. Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration. Cell Transplant 2002, 11(6):593-613.
13. Zhang S.X., Huang F., Gates M., White J., Holmberg E.G. Extensive scarring induced by chronic intrathecal tubing augmented cord tissue damage and worsened functional recovery after rat spinal cord injury. J Neurosci Methods 2010, 191(2):201-207.
14. Habeeb A.F. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 1966, 14(3):328-336.
15. Morrissey T.K., Kleitman N., Bunge R.P. Isolation and functional characterization of Schwann cells derived from adult peripheral nerve. J Neurosci 1991, 11(8):2433-2442.
16. Wood P.M. Separation of functional Schwann cells and neurons from normal peripheral nerve tissue. Brain Res 1976, 115(3):361-375.
17. Naldini L., Blomer U., Gage F.H., Trono D., Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996, 93(21):11382-11388.
18. Barakat D.J., Gaglani S.M., Neravetla S.R., Sanchez A.R., Andrade C.M., Pressman Y., et al. Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord. Cell Transplant 2005, 14(4):225-240.
19. Blits B., Kitay B.M., Farahvar A., Caperton C.V., Dietrich W.D., Bunge M.B. Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci 2005, 23(5-6):313-324.
20. Puckett W.R., Hiester E.D., Norenberg M.D., Marcillo A.E., Bunge R.P. The astroglial response to Wallerian degeneration after spinal cord injury in humans. Exp Neurol 1997, 148(2):424-432.
21. Cote M.P., Hanna A., Lemay M.A., Ollivier-Lanvin K., Santi L., Miller K., et al. Peripheral nerve grafts after cervical spinal cord injury in adult cats. Exp Neurol 2010, 225(1):173-182.
22. Cote M.P., Amin A.A., Tom V.J., Houle J.D. Peripheral nerve grafts support regeneration after spinal cord injury. Neurotherapeutics 2011, 8(2):294-303.
23. Fortun J., Hill C.E., Bunge M.B. Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci Lett 2009, 456(3):124-132.
24. Hill C.E., Hurtado A., Blits B., Bahr B.A., Wood P.M., Bartlett Bunge M., et al. Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord. Eur J Neurosci 2007, 26(6):1433-1445.
25. Hill C.E., Moon L.D., Wood P.M., Bunge M.B. Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia 2006, 53(3):338-343.
26. Taddei M.L., Giannoni E., Fiaschi T., Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol 2012, 226(2):380-393.
27. Koda M., Someya Y., Nishio Y., Kadota R., Mannoji C., Miyashita T., et al. Brain-derived neurotrophic factor suppresses anoikis-induced death of Schwann cells. Neurosci Lett 2008, 444(2):143-147.
28. Novikova L.N., Pettersson J., Brohlin M., Wiberg M., Novikov L.N. Biodegradable poly-beta-hydroxybutyrate scaffold seeded with Schwann cells to promote spinal cord repair. Biomaterials 2008, 29(9):1198-1206.
29. Gros T., Sakamoto J.S., Blesch A., Havton L.A., Tuszynski M.H. Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials 2010, 31(26):6719-6729.
30. Tabesh H., Amoabediny G., Nik N.S., Heydari M., Yosefifard M., Siadat S.O., et al. The role of biodegradable engineered scaffolds seeded with Schwann cells for spinal cord regeneration. Neurochem Int 2009, 54(2):73-83.
31. Bunge M.B. Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med 2008, 31(3):262-269.
32. Straley K.S., Foo C.W., Heilshorn S.C. Biomaterial design strategies for the treatment of spinal cord injuries. J Neurotrauma 2010, 27(1):1-19.
33. Bamber N.I., Li H., Lu X., Oudega M., Aebischer P., Xu X.M. Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci 2001, 13(2):257-268.
34. Xu X.M., Guenard V., Kleitman N., Aebischer P., Bunge M.B. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 1995, 134(2):261-272.
35. Olson H.E., Rooney G.E., Gross L., Nesbitt J.J., Galvin K.E., Knight A., et al. Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A 2009, 15(7):1797-1805.
36. Bregman B.S., Coumans J.V., Dai H.N., Kuhn P.L., Lynskey J., McAtee M., et al. Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog Brain Res 2002, 137:257-273.
37. Kang C.E., Poon P.C., Tator C.H., Shoichet M.S. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. Tissue Eng Part A 2009, 15(3):595-604.
38. Yuen E.C., Mobley W.C. Therapeutic applications of neurotrophic factors in disorders of motor neurons and peripheral nerves. Mol Med Today 1995, 1(6):278-286.
39. Henriques A., Pitzer C., Schneider A. Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?. Front Neurosci 2010, 4(32):1-14.
40. Friedman J.A., Windebank A.J., Moore M.J., Spinner R.J., Currier B.L., Yaszemski M.J. Biodegradable polymer grafts for surgical repair of the injured spinal cord. Neurosurgery 2002, 51(3):742-751. discussion 751-752.
41. Agrawal C.M., Athanasiou K.A. Technique to control pH in vicinity of biodegrading PLA-PGA implants. J Biomed Mater Res 1997, 38(2):105-114.
42. Chen P.R., Chen M.H., Sun J.S., Chen M.H., Tsai C.C., Lin F.H. Biocompatibility of NGF-grafted GTG membranes for peripheral nerve repair using cultured Schwann cells. Biomaterials 2004, 25(25):5667-5673.
43. Haniu M., Montestruque S., Bures E.J., Talvenheimo J., Toso R., Lewis-Sandy S., et al. Interactions between brain-derived neurotrophic factor and the TRKB receptor. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking. J Biol Chem 1997, 2(40):25296-25303.
44. Hanthamrongwit M., Reid W.H., Grant M.H. Chondroitin-6-sulphate incorporated into collagen gels for the growth of human keratinocytes: the effect of cross-linking agents and diamines. Biomaterials 1996, 17(8):775-780.
45. Okada N., Muraoka E., Fujisawa S., Machino M. Effects of visible light-irradiated camphorquinone and 9-fluorenone on murine oral mucosa. Dent Mater J 2008, 27(6):809-813.
46. Louis R. Spinal stability as defined by the three-column spine concept. Anat Clin 1985, 7(1):33-42.
47. Zhang J.Y., Luo X.G., Xian C.J., Liu Z.H., Zhou X.F. Endogenous BDNF is required for myelination and regeneration of injured sciatic nerve in rodents. Eur J Neurosci 2000, 12(12):4171-4180.
48. Peng H.B., Yang J.F., Dai Z., Lee C.W., Hung H.W., Feng Z.H., et al. Differential effects of neurotrophins and Schwann cell-derived signals on neuronal survival/growth and synaptogenesis. J Neurosci 2003, 23(12):5050-5060.
49. Li C., Sajiki T., Nakayama Y., Fukui M., Matsuda T. Novel visible-light-induced photocurable tissue adhesive composed of multiply styrene-derivatized gelatin and poly(ethylene glycol) diacrylate. J Biomed Mater Res B Appl Biomater 2003, 66(1):439-446.
50. Hoshikawa A., Nakayama Y., Matsuda T., Oda H., Nakamura K., Mabuchi K. Encapsulation of chondrocytes in photopolymerizable styrenated gelatin for cartilage tissue engineering. Tissue Eng 2006, 12(8):2333-2341.
51. Miyazu K., Kawahara D., Ohtake H., Watanabe G., Matsuda T. Luminal surface design of electrospun small-diameter graft aiming at in situ capture of endothelial progenitor cell. J Biomed Mater Res B Appl Biomater 2010, 94(1):53-63.
52. Nakayama Y., Ji-Youn K., Nishi S., Ueno H., Matsuda T. Development of high-performance stent: gelatinous photogel-coated stent that permits drug delivery and gene transfer. J Biomed Mater Res 2001, 57(4):559-566.
53. Chernousov M.A., Yu W.M., Chen Z.L., Carey D.J., Strickland S. Regulation of Schwann cell function by the extracellular matrix. Glia 2008, 56(14):1498-1507.
54. Jurga M., Dainiak M.B., Sarnowska A., Jablonska A., Tripathi A., Plieva F.M., et al. The performance of laminin-containing cryogel scaffolds in neural tissue regeneration. Biomaterials 2011, 32(13):3423-3434.
55. King V.R., Hewazy D., Alovskaya A., Phillips J.B., Brown R.A., Priestley J.V. The neuroprotective effects of fibronectin mats and fibronectin peptides following spinal cord injury in the rat. Neuroscience 2010, 168(2):523-530.
56. Lykissas M.G., Batistatou A.K., Charalabopoulos K.A., Beris A.E. The role of neurotrophins in axonal growth, guidance, and regeneration. Curr Neurovasc Res 2007, 4(2):143-151.
57. Tonge D., Edstrom A., Ekstrom P. Use of explant cultures of peripheral nerves of adult vertebrates to study axonal regeneration in vitro. Prog Neurobiol 1998, 54(4):459-480.